San Diego Mesenchymal Stem Cells
Request a Consultation
San Diego · Mesenchymal stem cells, explained

The most‑studied cell in regenerative medicine — minus the hype.

Mesenchymal stem cells (MSCs) are adult stem/stromal cells able to differentiate into several tissue types — like bone, cartilage, and fat — in the laboratory. They are the workhorse of regenerative research. Here's what MSCs actually are, how they differ from exosomes, what the research shows, and the honest compliance picture a responsible provider will give you.

Education first Physician‑guided Straight about the science
What they are
Adult stem/stromal cells (multipotent)
Can become
Bone, cartilage, fat and more, in the lab
Sources
Bone marrow, adipose (fat), umbilical cord
FDA status (U.S.)
Most applications investigational, not approved
Start here

What mesenchymal stem cells actually are

Mesenchymal stem cells — MSCs — are adult stem/stromal cells found in tissues like bone marrow, fat, and umbilical cord. In the laboratory, they can differentiate into several cell types, and they release signaling factors that influence surrounding cells. The term was popularized in the early 1990s, and MSCs have since become the most extensively studied cell in regenerative medicine.1,2

Here's the honest framing this field needs: "most‑studied" is not the same as "proven" or "approved." In the United States, most MSC therapies remain investigational and are not FDA‑approved for the conditions commonly marketed. The research is genuinely active — and genuinely still unfolding.

The key distinction

MSCs vs. exosomes — cells, or the signals cells send

They're related — MSCs even produce exosomes — but they are not the same approach.

Mesenchymal stem cells

  • Living cells that can differentiate into multiple tissue types.2
  • The approach delivers the cells themselves.
  • Sourced from bone marrow, fat, or cord tissue.

Exosomes

  • Cell‑free vesicles that cells — including MSCs — secrete.
  • The approach focuses on the signaling cargo, not the cells.
  • A "cell‑free" area of study.
Important: This comparison is educational. In the U.S., most MSC and exosome applications are not FDA‑approved for the conditions commonly marketed, and no outcome is guaranteed. Only a licensed physician can assess what is appropriate and lawful for an individual.
The research

What scientists study MSCs for

Active research areas — described for education, not as claims of benefit. (References below.)

Differentiation

Multipotency

The lab‑studied ability to become bone, cartilage, fat, and other cell types.2

Signaling

Paracrine effects

The signaling factors MSCs release that influence nearby cells and tissue environments.1

Immune

Immune modulation

Studied for effects on immune responses — an area of significant research interest.3

Orthopedic

Musculoskeletal research

Explored in tissue and joint repair models — investigational, not proven treatment.4

Sourcing

Tissue origin

How bone marrow‑, adipose‑, and cord‑derived MSCs are isolated and characterized.4

The honest caveat

Clinical stage

Many human trials are ongoing; investigational status means results are not the same as approval.4

Before you believe the hype…

What an honest MSC conversation sounds like

MSCs attract heavy marketing. These are the things worth understanding first:

  • Why "most‑studied" is a statement about research volume — not about proof or approval.
  • Why the source of MSCs — bone marrow, fat, or cord — and how they're characterized actually matters.
  • The difference between MSCs the cells and the exosomes they secrete.
  • Why "investigational" is a specific, honest status — not a synonym for "proven."
  • The one question that separates science‑led guidance from a sales pitch.
The compliance facts

What we will always tell you about MSCs

  • In the U.S., most MSC therapies are investigational and not FDA‑approved for the conditions commonly marketed.
  • No outcome is guaranteed. Any provider promising a specific result is ahead of the science and the law.
  • Source, characterization, provider, and your individual health all affect safety — which only a licensed physician can assess.
  • This site is educational — not medical advice, a diagnosis, or a treatment offer.
This is not medical advice. Regenerative and MSC science is evolving and heavily regulated. Always consult a licensed physician before making any health decision.
Questions

Mesenchymal stem cells, answered honestly

What are mesenchymal stem cells (MSCs)?

Adult stem/stromal cells able to differentiate into several tissue types such as bone, cartilage, and fat in the laboratory. They are the most extensively studied cell in regenerative medicine. This page is educational.

How are MSCs different from exosomes?

MSCs are living cells; exosomes are cell‑free vesicles that cells (including MSCs) secrete. The MSC approach delivers the cells; the exosome approach focuses on the signaling cargo cells send.

Are MSC therapies FDA‑approved?

In the United States, most MSC therapies are investigational and not FDA‑approved for the conditions commonly marketed. Only a licensed physician can advise on what is appropriate and lawful. Educational, not medical advice.

What are MSCs studied for?

MSC research spans orthopedic and musculoskeletal repair, immune modulation, and other areas. Much is investigational; research findings are not the same as proven or approved treatments.

Where do MSCs come from?

MSCs can be isolated from tissues such as bone marrow, adipose (fat) tissue, and umbilical cord tissue. Source and characterization affect what a preparation actually contains, which is why documentation matters.

Do MSC therapies guarantee results?

No. Outcomes vary and are never guaranteed. Because most MSC applications are investigational, any promise of a specific result is a claim the science and regulations do not support.

Are MSC therapies safe?

Safety depends on the specific approach, source, provider, and individual, and no procedure is risk‑free. Suitability and risks can only be assessed by a licensed physician.

How do I learn more responsibly?

Request a consultation with a licensed provider who can discuss the current science honestly and whether anything is appropriate for your situation.

References

Selected research

  1. Caplan AI. Mesenchymal stem cells. Journal of Orthopaedic Research. 1991;9(5):641–650.
  2. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–147.
  3. Le Blanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graft‑versus‑host disease with third party haploidentical mesenchymal stem cells. The Lancet. 2004;363(9419):1439–1441.
  4. Squillaro T, Peluso G, Galderisi U. Clinical Trials With Mesenchymal Stem Cells: An Update. Cell Transplantation. 2016;25(5):829–848.

References are provided for educational context and describe scientific research, not endorsements of any specific therapy or outcome. Consult the primary sources and a licensed physician.

The honest next step

Understand the cell. Talk to someone who'll keep it honest.

Request a consultation with a licensed provider. Science over hype — always.